The 10 Most Recommended Pharma & Life Sciences Solution providers in 2019

1T
HE
MOST RECOMMENDED
PHARMA &
L FE SCIENCES
SOLUTION PROVIDERS IN 2019
Hard Work is all it takes to Succeed
Nucleome has invested its entire seed funding in building a
well-equipped laboratory with sophisticated wet lab
instruments and servers like BigData Decoder which are
specially designed for next generation sequencing data
analysis along with NGS analysis pipelines on online cloud
servers like Google genomics, Amazon Web Server and
DNA nexus.
It has successfully completed various projects in association
with various International organizations like CNRGV
(France), Fasteris SA (Switzerland), Koppert Biological
Systems (The Netherlands), Cold Spring Harbor Laboratory
(USA), McDonnell Genome Institute, (USA), University of
California (USA), Yale University (USA), New York
Genome Center (USA), Washington University(USA), The
Queensland Alliance for Agriculture and Food
Innovation(Australia) and Indian institutes like CCMB,
CIBA, IHBT, NRCP, NRCPB, ILS and NDDB. Nucleome
has also built a sound association with all the major
institutes under ICAR, CSIR, DBT and various hospitals
including Tata Memorial Hospital Mumbai and private
organisations like ITC and Beej Sheetal Seeds.
Nucleome was awarded ‘India’s 20 Most Promising
Pharma & Life Science Technology Solution Provider
Companies 2016’ by a leading magazine.
Using Nucleome’s services researchers have published
several Research Papers.
Paper in the field of Animal Genomics:
• The Cuon Enigma: Genome survey and comparative
genomics of the endangered Dhole 1 (Cuon alpinus) in
bioRxiv
• High coverage genome sequencing and identification of
genomic variants in Bengal tiger (Panthera tigris tigris)
in bioRxiv
• Genome Plasticity in Cultured Leishmania donovani:
Comparison of Early and Late Passages in Frontiers in
Microbiology
• RNA-Seq Revealed Expression of Many Novel Genes
Associated With Leishmania do no vani Persistence and
clearance in the Host Macrophage in Frontiers in
Cellular and Infection Microbiology
Papers in the field of Agri Genomics:
• Analysis of DNA methylome and transcriptome
profiling following Gibberellin A3 (GA3) foliar
application in Nicotiana tabacum L. in Indian Journal
of Plant Physiology
• Identification of candidate pathogenicity determinants of
Rhizoctonia
solani AG1-IA,
which causes
sheath blight
disease in rice in
Current Genetics
of Springer
Nature
• Alterations in rice
chloroplast
integrity,
photosynthesis
Company’s expertise
lies in Sequencing
and Analysis of de
novo genome using
hybrid assembly
approach,
Transcriptome,
and genome
resequencing data
and metabolome associated with pathogenesis of
Rhizoctonia solani in Scientific Reports
• Sequencing, Denovo Assembly, Functional Annotation
and Analysis of Phyllanthus amarus Leaf Transcriptome
Using the Illumina Platform in Frontiers in Plant
Science
• Analysis of high iron rice lines reveals new miRNAs
that target iron transporters in roots in Journal of
Experimental Botany
Lapping up the Opportunities
The Pharma and life science industry is bustling with ideas
and applications. The increasing application of genomics in
biotech and pharmaceutical research and development has
created a huge commercial market for sequencing and
bioinformatics worldwide. The explosive growth of
biological techniques necessitates the acquisition,
processing, analysis, and integration of the data. These
immense amounts of data are generated by the experiments
as diverse as genomics, cloning, expression analysis,
genotyping, cellular analysis and others. Many young
entrepreneurs are looking at it as an opportunity for new
startups. The founders advise them saying “Dare to
dream…..Follow your dream….Live your dream…..Strive
hard to achieve your dream.”
For a Better Future
Nucleome aims at a healthier future through revolutionary
genetic analysis solutions. It is committed to generating
rapid, appropriate and high-quality results which can create
a great difference in research projects.
Nucleome’s focus has always been in the field of Plant,
Animal and Human Genomics and is planning to strengthen
its position in this field. It has planned to raise its SeriesA
funding to expand its infrastructure by building India’s
largest genomics and supercomputing bioinformatics
facility. It aims to fund and propel its Population genomics
program to sequence 10,000 human genomes and 100,000
exomes of various cancer and diabetics patients in India.
APRIL 2019 |
| 39